| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 60.901 | 98.338 | 125.847 | 119.587 | 123.145 | 167.435 | 140.087 | 154.715 | 201.272 | 208.579 |
| Total Income - EUR | 61.017 | 98.810 | 126.674 | 120.104 | 123.844 | 169.114 | 140.932 | 155.999 | 202.942 | 228.343 |
| Total Expenses - EUR | 44.577 | 80.581 | 92.417 | 91.292 | 100.614 | 122.346 | 108.689 | 131.178 | 169.988 | 170.188 |
| Gross Profit/Loss - EUR | 16.441 | 18.229 | 34.257 | 28.813 | 23.230 | 46.768 | 32.243 | 24.820 | 32.954 | 58.155 |
| Net Profit/Loss - EUR | 14.610 | 17.241 | 32.999 | 27.617 | 21.986 | 45.341 | 31.182 | 23.260 | 31.127 | 52.618 |
| Employees | 2 | 3 | 3 | 0 | 3 | 4 | 3 | 2 | 3 | 2 |
Check the financial reports for the company - Annemedica Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 18.131 | 17.433 | 16.031 | 14.915 | 13.819 | 15.865 | 42.445 | 35.588 | 29.332 | 22.979 |
| Current Assets | 19.683 | 32.016 | 41.731 | 34.712 | 36.206 | 46.809 | 58.914 | 54.761 | 70.043 | 89.281 |
| Inventories | 12.741 | 21.175 | 19.010 | 21.295 | 28.956 | 34.876 | 45.766 | 50.283 | 56.321 | 64.234 |
| Receivables | 2.039 | 1.436 | 7.613 | 2.560 | 1.508 | 3.694 | 1.124 | 68 | 2.900 | 2.040 |
| Cash | 4.903 | 9.405 | 15.108 | 10.857 | 5.742 | 8.239 | 12.024 | 4.410 | 10.821 | 23.008 |
| Shareholders Funds | 23.784 | 18.181 | 34.017 | 28.625 | 22.978 | 57.423 | 87.331 | 75.750 | 83.459 | 104.672 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 14.029 | 31.268 | 23.746 | 21.002 | 27.047 | 5.251 | 14.028 | 14.599 | 15.915 | 7.588 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Annemedica Pharm Srl